首页> 外文期刊>Disease markers >IL-23 gene expression in PBMCs of patients with coronary artery disease
【24h】

IL-23 gene expression in PBMCs of patients with coronary artery disease

机译:冠状动脉疾病患者PBMC中的IL-23基因表达

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Both adaptive and innate immune systems are involved in coronary artery disease (CAD). The aim of this study was to evaluate TH17 cytokines expression profiles in un-stimulated peripheral blood lymphocytes (PBMCs) of patients with coronary artery disease. Methods: Expression profiles of IL-17, IL-23, and TGF-/51 were determined in individuals with and without CAD using Real-time PCR. Results: A significant decrease in IL-23 gene expression in un-stimulated PBMCs of patients with CAD compared to those without CAD was found (p = 0.003, OR - 0.045, 95% CI: 0.006-0.355). Conclusion: Our data reinforce the potential role of the IL-23 as a critical regulatory molecule that bridges the innate and adaptive arms of the immune system in the complex mechanisms associated with the development of atherosclerosis.
机译:目的:适应性和先天免疫系统均参与冠状动脉疾病(CAD)。 本研究的目的是评估冠状动脉疾病患者的未刺激外周血淋巴细胞(PBMC)中的细胞因子表达谱。 方法:使用实时PCR,在具有和不含CAD的个体中测定IL-17,IL-23和TGF-/ 51的表达谱。 结果:发现与CAD患者的未刺激PBMC中IL-23基因表达的显着降低(P = 0.003,或 - 0.045,95%CI:0.006-0.355)。 结论:我们的数据增强了IL-23作为临危调节分子的潜在作用,该分子桥接免疫系统的先天和自适应臂,其在与动脉粥样硬化发育相关的复杂机制中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号